Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yan, Linlin ^a,b   Zhang, Henghui ^b   Ma, Hui ^b   Liu, Di ^c   Li, Wei ^c   Kang, Yulin ^d   Yang, Ruifeng ^b   Wang, Jianghua ^b   He, Gaixia ^b   Xie, Xingwang ^b   Wang, Hao ^b   Wei, Lai ^b   Lu, Zuhong ^d   Shao, Qixiang ^a   Chen, Hongsong ^b  

^a JIANGSU UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

^d PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; CLASSIFICATION; CLUSTER ANALYSIS; FEMALE; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MALE; MUTATION; PREVALENCE; PROMOTER REGION; REPRODUCIBILITY; VIROLOGY; YOUNG ADULT;

ADULT; AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MUTATION; PREVALENCE; PROMOTER REGIONS, GENETIC; RECOMBINATION, GENETIC; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84949595416     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17950     Document Type: Article

References (34)

1. Summers, J. & Mason, W. S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29, 403-15 (1982).
2. Chotiyaputta, W. & Lok, A. S. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol. 6, 453-62 (2009).
3. Buckwold, V. E., Xu, Z., Chen, M., Yen, T. S. & Ou, J. H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol. 70, 5845-51 (1996).
4. Carman, W. F. et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 2, 588-91 (1989).
5. Tseng, T. C. et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 64, 292-302 (2015).
6. Yang, H. I. et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 100, 1134-43 (2008).
7. Chou, Y. C. et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut. 57, 91-7 (2008).
8. Liu, C. J. et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis. 193, 1258-65 (2006).
9. Kao, J. H., Chen, P. J., Lai, M. Y. & Chen, D. S. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology. 124, 327-34 (2003).
10. Yang, H. C. et al. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferoninduced hepatitis B e antigen seroconversion. Hepatology. 57, 934-43 (2013).
11. Rothberg, J. M. et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 475, 348-52 (2011).
12. Fujimoto, M. et al. Application of ion torrent sequencing to the assessment of the effect of alkali ballast water treatment on microbial community diversity. PLoS One. 9, e107534 (2014).
13. Xu, Z. et al. Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform. PLoS One. 9, e100442 (2014).
14. Chu, C. M. et al. Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection. Br J Cancer. 107, 2010-5 (2012).
15. Xu, Z. et al. Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol. 46, 391-400 (2011).
16. Llovet, J. M. & Lok, A. Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma. J Natl Cancer Inst. 100, 1121-3 (2008).
17. Yin, J. et al. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol. 106, 81-92 (2011).
18. Chen, C. H. et al. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol. 43, 6000-6 (2005).
19. Yu, M. W. et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 97, 265-72 (2005).
20. Kao, J. H., Chen, P. J., Lai, M. Y. & Chen, D. S. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 118, 554-9 (2000).
21. Kao, J. H., Wu, N. H., Chen, P. J., Lai, M. Y. & Chen, D. S. Hepatitis B genotypes and the response to interferon therapy. J Hepatol. 33, 998-1002 (2000).
22. Pivert, A. et al. Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus. J Med Virol. 87, 529-35 (2015).
23. Seo, Y. et al. Response to interferon-alpha in chronic hepatitis B with and without precore mutant strain detected by mutation sitespecific assay. J Clin Gastroenterol. 38, 460-4 (2004).
24. Scaglioni, P. P., Melegari, M. & Wands, J. R. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology. 233, 374-81 (1997).
25. Yoo, B. C. et al. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 38, 98-103 (2003).
26. Chun, Y. K. et al. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection. Hepatology. 32, 1154-62 (2000).
27. Pang, A., Yuen, M. F., Yuan, H. J., Lai, C. L. & Kwong, Y. L. Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversion. J Hepatol. 40, 1008-17 (2004).
28. Chen, W. N. & Oon, C. J. Mutations and deletions in core promoter and precore stop codon in relation to viral replication and liver damage in Singaporean hepatitis B virus carriers. Eur J Clin Invest. 30, 787-92 (2000).
29. Fang, Z. L. et al. The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis. J Hepatol. 50, 273-80 (2009).
30. Liaw, Y. F., Lau, G. K., Kao, J. H., Gane, E. & Hepatitis B. e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig Dis Sci. 55, 2727-34 (2010).
31. Liu, C. J. et al. Viral factors correlate with hepatitis B e antigen seroconversion in patients with chronic hepatitis B. Liver Int. 26, 949-55 (2006).
32. Tseng, T. C. et al. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-alpha-2a therapy. Antivir Ther. 16, 629-37 (2011).
33. Chu, C. M. & Liaw, Y. F. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a longterm follow-up. Hepatology. 45, 1187-92 (2007).
34. Ma, H., Yang, R. F. & Wei, L. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients. J Gastroenterol Hepatol. 25, 1498-506 (2010).